Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer

This publication has 28 references indexed in Scilit:

• A Critical Analysis of the Interpretation of Biochemical Failure in Surgically Treated Patients Using the American Society for Therapeutic Radiation and Oncology Criteria
  Journal of Urology, 2002
• Quality of Life after Radical Prostatectomy or Watchful Waiting
  New England Journal of Medicine, 2002
• A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
  New England Journal of Medicine, 2002
• Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
  Cancer, 2002
• The role of external beam irradiation in patients undergoing prostate brachytherapy
  Urologic Oncology: Seminars and Original Investigations, 2000
• RETROSPECTIVE COMPARISON OF RADICAL RETROPUBIC PROSTATECTOMY AND ¹²⁵ IODINE BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER
  Journal of Urology, 1999
• Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml
  International Journal of Radiation Oncology*Biology*Physics, 1997
• More on the uro-oncology research group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
  New England Journal of Medicine, 1987